AstraZeneca: Company Overview, Stakeholder Mapping, PESTLE Analysis, Porter's Five Forces, SWOT Analysis, Industry Life Cycle

AstraZeneca

Table of Contents
INTRODUCTION...........................................................................................................................1
MAIN BODY...................................................................................................................................1
Company Overview................................................................................................................1
Stakeholder Mapping..............................................................................................................3
PESTLE Analysis...................................................................................................................4
Porter's Five Forces................................................................................................................7
SWOT Analysis......................................................................................................................9
Industry Life Cycle...............................................................................................................11
Key Findings........................................................................................................................13
CONCLUSION..............................................................................................................................13
References:.....................................................................................................................................15

INTRODUCTION
Strategic management can be defined as the proactive administration in an organization
in which strategies plays an important role in formulating the policies, rules, regulations, norms,
goals and objectives. Every function is performed strategically such as human resource
management, marketing management, operations management and many more (Sullivan,
Thomas and Rosano, 2018). Sustainability can be defined as the efficient use of the resources
with minimal wastages of the time, energy and cost. Environment sustainability is for the safety
of environment from various different hazards such as pollution, gas emissions and many more
that are caused because of industries operating nationally or internationally. Pharmaceutical
industry deals with the chemicals and medicines to supply in hospitals or to the doctors so that
they can generate and prescribe it to the patients or the person who require it. Organization
chosen here is the AstraZeneca, it is one of the leading international pharmaceutical company
based in UK in 1999. It offers products and services such as chemicals and medicines specially
for the diseases like oncology, cardiovascular, gastrointestinal, infection, neuroscience,
respiratory and inflammation areas. The following discussion is based on the company overview
of AstraZeneca, stakeholder mapping analysis, pestle analysis, porter's five forces analysis, swot
analysis, industry life cycle analysis and key findings with proper evaluation and conclusion.
MAIN BODY
Company Overview
Vision
AstraZeneca’s vision statement is to make commitment for purposeful variation to
patient's health which is discovered on advanced science. In a quickly dynamic world, their
vision is to transform the way and where their business to grab most of the opportunities that
new sciences and engineering bring up for new medication.
Mission
AstraZeneca’s mission is to generate a significant difference in the lives of the people
they serve and the employees who work under them.
Values
Their values examine how they work collectively and the behaviours that are
constitutional to their thrust for succession in accomplishment of the goals. Their values lead
1

decision making, determine their impression and surrogate a powerful AstraZeneca culture
(Willigers, 2020).
Key Strategies
AstraZeneca are impelled by advanced science and their enterprising culture, they are
centred on the bringing of life-changing medication that are accelerating development and
contributively worth to patients and society. At the same instance, the world around them is ever-
changing and the load of illness is increasing. AstraZeneca’s key strategies are to answer by
fostering their direction on growth and development through invention - being more patient-
centric, performing more with practical application, digital and information and progressing
more cutting-edge scientific discipline by grabbing the opportunity in Covid-19 pandemic to
develop vaccine for the same.
Offering
They target on forward-looking science and leading activity in their three primary
medical care areas: Oncology, Cardiovascular, Renal and Metabolism and Respiratory diseases.
Revenues
18.67 billion pounds in 2020: The Anglo-Swedish pharmaceutical giant reported product
sales totalling 18.60 billion pounds for 2020. Total revenue came in at 18.18 billion pounds for
the year, and 5.34 billion pounds for the fourth quarter. Last year's performance marked as
significant step forward for AstraZeneca.
Location
Cambridge, England, United Kingdom.
2